Human Genome Epidemiology Literature Finder
|
Records 1 - 10 (of 10 Records) |
| Query Trace: Headache and CYP2D6[original query] |
|---|
| [Rationale and methods of the UNAMET study (dose- and CYP2D6-genotype-dependent adverse drug reactions of metoprolol)--a contribution to quality improvement in pharmacotherapy]. Zeitschrift fur arztliche Fortbildung und Qualitatssicherung 2005 1 98 (8): 689-94. Fux Richard, Meisner Christoph, Schwab Matthias, Lorenz Gernot, Mörike Klaus, Gleiter Christoph |
| Effect of polymorphisms on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers. Human psychopharmacology 2014 Sep 29 (5): 459-69. Cabaleiro Teresa, Ochoa Dolores, López-Rodríguez Rosario, Román Manuel, Novalbos Jesús, Ayuso Carmen, Abad-Santos Francis |
| The role of PON1 and CYP2D6 genes in susceptibility to organophosphorus chronic intoxication in Egyptian patients. Neurotoxicology 2015 Dec . Khattab Amr Mohamed Tawfik, Zayed Abeer Ahmed, Ahmed Asmaa Ismail, Abdelaal Aly Gamaleldin, Mekdad Alaa Abdelham |
| Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects. Drug design, development and therapy 2017 11 713-723. Shin Dongseong, Lee SeungHwan, Yi Sojeong, Yoon Seo Hyun, Cho Joo-Youn, Bahng Mi Young, Jang In-Jin, Yu Kyung-Sa |
| Effects of CYP2D6 genetic polymorphisms on the efficacy and safety of fluvoxamine in patients with depressive disorder and comorbid alcohol use disorder. Pharmacogenomics and personalized medicine 2018 11 113-119. Zastrozhin Mikhail Sergeevich, Grishina Elena Anatolievna, Denisenko Nataliya Petrovna, Skryabin Valentin Yurievich, Markov Dmitry Dmitrievich, Savchenko Ludmila Mikhailovna, Bryun Evgeny Alekseevich, Sychev Dmitry Alekseevi |
| Does co-administration of paroxetine change oxycodone analgesia: An interaction study in chronic pain patients. Scandinavian journal of pain 2017 Dec 1 (1): 24-33. Lemberg K K, Heiskanen T E, Neuvonen M, Kontinen V K, Neuvonen P J, Dahl M-L, Kalso E |
| Metabolizing profile of the cytochrome pathway CYP2D6, CYP3A4 and the ABCB 1 transporter in Spanish patients affected by Gaucher disease. Chemico-biological interactions 2021 May 109527. Almeida-Calpe A, López de Frutos L, Medrano-Engay B, García-García C B, Ribate M P, Giraldo |
| CYP2D6 in the Brain: Potential Impact on Adverse Drug Reactions in the Central Nervous System-Results From the ADRED Study. Frontiers in pharmacology 2021 12 624104. Just Katja S, Dormann Harald, Freitag Mathias, Schurig Marlen, Böhme Miriam, Steffens Michael, Scholl Catharina, Seufferlein Thomas, Graeff Ingo, Schwab Matthias, Stingl Julia |
| Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study. International journal of molecular sciences 2023 7 24 (13): . Laura Agulló, Isidro Aguado, Javier Muriel, César Margarit, Alba Gómez, Mónica Escorial, Astrid Sánchez, Alicia Fernández, Ana M Pei |
| Investigation of the differences in the pharmacokinetics of CYP2D6 substrates, desipramine and dextromethorphan in healthy African subjects carrying the allelic variants CYP2D6*17 and CYP2D6*29 when compared with normal metabolizers. Journal of clinical pharmacology 2023 10 . Venugopal P Marasanapalle, Collen Masimirembwa, Rama Sivasubramanian, Sarfaraz Sayyed, Armin Weinzierl-Hinum, Dheeraj Mehta, Nyasha Nicole Kapungu, Comfort Kanji, Roslyn Thelingwani, Julia Za |
- Page last reviewed:Feb 1, 2024
- Content source: